Skip to content

Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI

Novel Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MR for Non-Invasive Evaluation of Coronary Artery Disease

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02550366
Enrollment
44
Registered
2015-09-15
Start date
2016-01-01
Completion date
2024-01-19
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease

Keywords

Cardiac MRI, Accelerate imaging, coronary artery disease

Brief summary

Coronary artery disease (CAD) is the leading cause of death in the United States. Cardiac MRI is a non-invasive non-ionizing technique for a comprehensive cardiac exam, which can be used in the diagnosis of CAD. In this work, the investigators will develop and validate techniques for accelerated cardiac MRI, offering better volumetric coverage of the heart, improved contrast, and superior spatial and temporal resolutions.

Detailed description

Coronary artery disease (CAD) is the leading cause of death in the United States, even though significant efforts have been made in prevention and diagnosis. The clinical gold standard for diagnosis of CAD is catheter-based invasive x-ray angiography, performed more than a million times per year. Of these examinations, up to 35% have been found to have no significant stenosis, yet these patients had to go through the potential risks and complications of an invasive test that further exposes the patient to ionizing radiation and iodinated contrast. Thus, non-invasive diagnostic alternatives are highly desirable. Cardiac MRI (CMR) provides a method for a comprehensive non-invasive cardiac exam, including contractile functional assessment (cine) to detect wall-motion abnormality, myocardial CMR perfusion for diagnosing perfusion defects, viability assessment using late gadolinium enhancement for evaluation of acute and chronic myocardial infarction, and coronary MRI for the identification of stenosis. CMR is advantageous in several respects, since it does not require ionizing radiation or iodinated contrast, thereby facilitating repeated or follow-up scanning. However, long data acquisition time remains as one of its main limitations. Several approaches have been studied to facilitate rapid CMR acquisition. Nonetheless, the acquisition time for high-resolution CMR remains long, and spatial and temporal resolution is traded off for acquisition time. Therefore, developments of methods to reduce the duration of data acquisition beyond what is available now are appealing. The investigators will develop novel reconstruction methodologies for high-resolution CMR that learn the anatomical structures in the images being reconstructed. The investigators will validate these techniques in a range of contrast-enhanced CMR imaging protocols, providing better volumetric coverage of the heart, efficient use of the contrast agents, and higher spatial and temporal resolution.

Interventions

MRI Contrast

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects 18 years and older * Cardiovascular disease patients referred from the Department of Cardiology, who do not meet any of the

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frameDescription
high-resolution approaches with existing standard resolution imaging technique1 and 3 yearsquantitative measures
infarct size,1 and 3 yearsquantitative measures
left and right ventricular volumes and masses,1 and 3 yearsquantitative measures
time-intensity-curve upslopes,1 and 3 yearsquantitative measures
Quantitative comparison of the proposed techniques with existing imaging techniques1 and 3 yearsvessel length and sharpness

Secondary

MeasureTime frameDescription
presence of infarct (yes/no dichotomous),1 and 3 yearsQualitative comparison
image quality (scores range from 1 [poor] to 4 [excellent]).1 and 3 yearsQualitative comparison
presence of stenosis (yes/no dichotomous)1 and 3 yearsQualitative comparison

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026